It was reported that during a manufacturing process for acoustic power sample testing with a vivid e9 ultrasound system at a ge healthcare ultrasound manufacturing site in (b)(4), the measured acoustic output value (ispta.3) of a p6d probe was above the 720mw/cm^2 acoustic output limitation recorded in document 560 (information for manufacturers seeking marketing clearance of diagnostic ultrasound systems and transducers).The conclusion of the internal investigation associated with this issue discovered an off-axis misalignment of the measuring tool.Additionally, a method for detecting off-axis misalignment and re-calculation of the ispta.3 was found and applied to all probes that went through acoustic power testing within the timespan the measurement tool was misaligned.The results concluded 14 probes may fail to meet the 720mw/cm^2 acoustic output limitation; six fall within a maximum estimated ispta.3 of 757mw/cm^2, and eight fall within a maximum estimated ispta.3 of 1024mw/cm^2.Ge's investigation currently is continuing.
|
Ge's investigation has completed.No systemic manufacturing process issue was found related to compliance with acoustic output guidelines and regulatory submissions.Probes in inventory that are under suspicion for ispta.3 > usl of 720mw/cm2 have been re-measured and dispositioned per manufacturing procedures.The issue is limited to a small number of probes, with small or moderate ispta deviations from expected values, combined with very low mi and low ti values.Ge's medical assessment concluded that biological effects are not reasonably expected, and thus it is concluded that field action is not required.
|